Targeted News Service

Ropes & Gray: Gilgamesh Pharmaceuticals Announces AbbVie Collaboration Up to Over $2B
May 14, 2024

BOSTON, Massachusetts, May 14 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray represented Gilgamesh Pharmaceuticals in a collaboration and option-to-license agreement with AbbVie to develop next-generation therapies for psychiatric disorders. The collaboration announced on May 13 will leverage AbbVie's experience in psychiatry medicine and Gilgamesh's innovative research platform to discover novel neuroplastogens for treatment of mood and anxiety . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form